Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D02CQN
|
||||
Former ID |
DNC011257
|
||||
Drug Name |
5-(4-chlorophenyl)-N-(2-methylbenzyl)nicotinamide
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [531169] | ||
Structure |
Download2D MOL |
||||
Formula |
C20H17ClN2O
|
||||
Canonical SMILES |
CC1=CC=CC=C1CNC(=O)C2=CN=CC(=C2)C3=CC=C(C=C3)Cl
|
||||
InChI |
1S/C20H17ClN2O/c1-14-4-2-3-5-16(14)13-23-20(24)18-10-17(11-22-12-18)15-6-8-19(21)9-7-15/h2-12H,13H2,1H3,(H,23,24)
|
||||
InChIKey |
MLDMXXWILKZITA-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Voltage-gated sodium channel subunit alpha Nav1.8 | Target Info | Inhibitor | [531169] | |
PN3 Na+ channel | Target Info | Inhibitor | [531169] | ||
Reactome | Interaction between L1 and Ankyrins | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.